Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome

Clínica e investigación en arteriosclerosis : publicación oficial de la Sociedad Española de Arteriosclerosis
Patricio López-Jaramillonombre del Grupo de Expertos de Latinoamérica

Abstract

The present document has been prepared by a group of experts, members of Cardiology, Endocrinology, Internal Medicine, Nephrology and Diabetes societies of Latin American countries, to serve as a guide to physicians taking care of patients with diabetes, hypertension and comorbidities or complications of both conditions. Although the concept of metabolic syndrome is currently disputed, the higher prevalence in Latin America of that cluster of metabolic alterations has suggested that metabolic syndrome is useful nosography entity in the context of Latin American medicine. Therefore, in the present document, particular attention is paid to this syndrome in order to alert physicians on a particular high- risk population, usually underestimated and undertreated. These recommendations results from presentation and debates by discussion panels during a 2-day conference held in Bucaramanga, in October 2012, and all the participants have approved the final conclusions. The authors acknowledge that the publication and diffusion of guidelines do not suffice to achieve the recommended changes in diagnostic or therapeutic strategies, and plan suitable interventions overcoming both physicians and patients from effectively adhering to guidel...Continue Reading

References

Dec 11, 1992·American Journal of Public Health·G L BurkeD R Jacobs
Feb 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A A Lopes, F K Port
Jul 24, 1993·BMJ : British Medical Journal·T Delamothe
Sep 1, 1993·Clinical and Experimental Hypertension : CHE·C A SilagyB P McGrath
Nov 14, 1997·Diabetes Care·J A Colwell
May 15, 1998·Journal of Human Hypertension·P O Ordúñez-GarcíaF J Nieto
Feb 23, 1999·Circulation·R J Shephard, G J Balady
Oct 27, 1999·JAMA : the Journal of the American Medical Association·M D CabanaH R Rubin
Nov 5, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·R WilksT Forrester
Sep 12, 2000·Journal of Human Hypertension·F Guerrero-RomeroR Alvarado-Ruiz
Jun 8, 2001·Circulation·C IribarrenJ V Selby
Jan 10, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·A BerberL Sánchez-Reyes
Feb 28, 2002·JAMA : the Journal of the American Medical Association·Ramachandran S VasanDaniel Levy
May 3, 2002·Journal of Human Hypertension·M E Díaz
Jun 11, 2002·Blood Pressure Monitoring·J A StaessenUNKNOWN Participants of the 2001 Consensus Conference on Ambulatory Blood Pressure Monitoring
Jul 18, 2002·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·C FilozofJ Braguinsky
Jul 24, 2002·Diabetologia·B Jönsson, UNKNOWN CODE-2 Advisory Board
Aug 16, 2002·Obesity Research·Teresa A SharpJames O Hill
Oct 16, 2002·Diabetologia·S S Soedamah-MuthuUNKNOWN EURODIAB Prospective Complications Study Group
Nov 9, 2002·Lancet·Majid EzzatiUNKNOWN Comparative Risk Assessment Collaborating Group
Mar 8, 2003·Stroke; a Journal of Cerebral Circulation·Salah-Eddine MegherbiUNKNOWN European BIOMED Study of Stroke Care Group
Apr 11, 2003·Lancet·Mariella AnselmiGianni Tognoni
Jun 6, 2003·The Journal of Clinical Endocrinology and Metabolism·Gerald M Reaven

❮ Previous
Next ❯

Citations

Mar 8, 2017·International Journal of Environmental Research and Public Health·Javier Martínez-TorresRobinson Ramírez-Vélez
Jul 28, 2016·Archivos de cardiología de México·José Kelvin Galvez-OlorteguiLuis Camacho-Saavedra

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.